US Patent 7396850 Pyrazole derivative as PPAR modulator
Patent 7396850 was granted and assigned to Eli Lilly and Company on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
The present invention is directed to a compound, {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid and pharmaceutical uses thereof.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07396850 Pyrazole derivative as PPAR modulator US Patent 7396850 Pyrazole derivative as PPAR modulator
Infobox
Patent Number
0739685000
Patent Number
739685000
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073968500
Date of Patent
July 8, 2008
0Patent Application Number
105372820
Date Filed
December 31, 2003
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073968500
Date of Patent
July 8, 2008
0Patent Application Number
105372820
Date Filed
December 31, 2003
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07396850 Pyrazole derivative as PPAR modulator
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07396850
Date of patent
July 8, 2008
Patent application number
10537282
Date Filed
December 31, 2003
Patent primary examiner
Find more entities like US Patent 7396850 Pyrazole derivative as PPAR modulator
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
